Audit Evidence Against Venture DNA Baseline
Evaluate the gathered assets directly against the defined gate criteria and core venture DNA parameters, including value proposition, unit economics, and target market sizing. The founder systematically cross-references performance data with strategic intent to detect discrepancies.
Completing this action reveals how effectively the venture's real-world progress matches its foundational strategic model. It validates whether the venture is building scalable enterprise value or simply meeting short-term activity targets.
The founder must present a side-by-side gap analysis mapping every gate criterion against documented evidence and core venture DNA metrics. The output must highlight exact margins of over- or under-performance across key performance indicators.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
What evidence proves that your current traction metrics validate the underlying venture DNA rather than a temporary anomaly?
- 2
Why does your customer acquisition cost data deviate from the original financial model defined in your venture DNA?
- 3
How does the collected user feedback challenge the core value proposition established during initial validation?
- 4
Where does your team's operational velocity fall short of the baseline expectations set for this development stage?
- 5
How robust is the alignment between your current unit economics and long-term gross margin targets?